CLL, Relapsed

Explore clinical trials studying CLL, Relapsed. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

CLL, Relapsed trial results

Recruiting

NCT07342478

Conditions: CLL, CLL (Chronic Lymphocytic Leukemia), CLL / SLL, +23 more
Locations: The Center for Cancer and Blood Disorders-Bethesda Bethesda, Maryland, United States

Optum Medical Group (Rhodes) P.C. Las Vegas, Nevada, United States

OSU Comprehensive Cancer Center Columbus, Ohio, United States

UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

Completed

NCT05621148

Conditions: Bruton Tyrosine Kinase Inhibitor, CLL, Refractory, CLL, Relapsed, +5 more
Locations: CHU Estaing - Hématologie Clinique Adulte Clermont-Ferrand, France

Centre Léon Bérard - Hématologie Lyon, France

Institut Paoli-Calmettes - Hématologie Clinique Marseille, France

MONTPELLIER - Hôpital Saint-Eloi - Hématologie Clinique Montpellier, France

Completed

NCT04512105

Conditions: AML, Adult, Acute Myeloid Leukemia, CLL, +22 more
Locations: Chao Family Comprehensive Cancer Center, University of California, Irvine Orange, California, United States